Acuity Reports Fiscal 2026 Second-Quarter Results
Acuity Inc. reported fiscal 2026 Q2 net sales of $1.1 billion, a 5% year‑over‑year increase, while operating profit climbed 21% to $133 million. Diluted earnings per share rose 26% to $3.09, and adjusted EPS reached $4.14, up 11%. The Acuity Intelligent Spaces (AIS) segment drove growth, posting a 44.7% sales surge to $248.1 million, whereas Acuity Brands Lighting (ABL) sales slipped 2.8%. The company generated $229.9 million of operating cash, lifted its quarterly dividend by 18% to $0.20, and repurchased $106 million of stock.
Half-Year Financial Report
Volta Finance Limited released its half‑year financial report for the period ending 31 January 2026. The Guernsey‑incorporated vehicle, listed on Euronext Amsterdam and the London Stock Exchange, continues to focus on collateralised loan obligations (CLOs) and structured‑finance assets under BNP Paribas Asset Management...
Blue Cross and Blue Shield of Minnesota Reports Financial Results for 2025
Blue Cross and Blue Shield of Minnesota posted a $353 million operating loss for 2025, equating to a 3 percent margin on $10.4 billion in fully insured premiums. Claims spending climbed to $9.8 billion, up $1.7 billion year‑over‑year, averaging roughly $27 million per day. A $150 million...
XWELL Reports Fiscal 2025 Results
XWELL, Inc. reported fiscal 2025 revenue of $29.2 million, while operating expenses fell about 10% and cost of sales dropped 13% year‑over‑year. The company opened a new wellness center in New York’s Penn Station and added two Florida locations, signaling a push...
VAYK Reported $2.0 Million Revenue for 2025 and Issued BOD Statement
Great Estate Blockchain, Inc. (OTC: VAYK) posted $2.0 million in revenue for fiscal 2025, a 300% increase year‑over‑year, and generated about $500,000 in operating profit. The company announced that its previously planned cryptocurrency and blockchain initiative has been indefinitely suspended after...
Vancity Reports Strong 2025 Performance. Asset Levels Reach a Record $41 Billion
Vancity announced its 2025 results, posting a record $41 billion CAD (≈$30 billion USD) in total assets and a net income of $69.9 million CAD (≈$52 million USD), up sharply from $5.8 million CAD the prior year. Core revenue climbed more than 30% to $675.4 million...
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. As of and for the Year Ended December 31,...
Ellomay Capital disclosed that its 16.9% indirect stake in Dorad Energy posted 2025 revenues of roughly NIS 2.65 billion (about $742 million) and operating profit of NIS 385 million (≈$108 million). The year’s results were pressured by a 22% revenue dip in June amid the Israel‑Iran...
Intermap Reports Fourth Quarter and Full Year 2025 Results
Intermap Technologies announced it has been down‑selected for all four remaining lots of Indonesia’s ILASP project, a potential $200 million opportunity, while reporting a 29% year‑over‑year increase in subscription and data revenue to $5.2 million. The company’s balance sheet strengthened dramatically, with...
Axe Compute Inc. Reports Full-Year 2025 Financial Results
Axe Compute Inc. completed a strategic transformation in 2025, shifting from drug discovery to an AI‑focused GPU compute and digital‑asset treasury business. The company raised $343.5 million through PIPE transactions, establishing a Strategic Compute Reserve of about 6.3 billion ATH tokens and...
HeartCore Reports Full Year 2025 Results
HeartCore Enterprises reported full‑year 2025 results, showing revenue of $9 million, a steep decline from $22.7 million the prior year after losing a large warrant deal. The company posted a net income of $5.5 million, driven largely by a gain from selling its...
Duos Technologies Reports Record 2025 Results, Driving Momentum in AI and Edge Infrastructure
Duos Technologies Group posted record 2025 results, delivering $27 million in revenue—a 270% year‑over‑year increase—and expanding its modular edge data‑center platform. The company raised a total of $110 million in capital, deployed 15 edge pods, and launched a GPU‑as‑a‑Service offering that will...
LanzaTech Reports Fourth Quarter and Fiscal Year 2025 Financial Results
LanzaTech posted FY 2025 revenue of $55.8 million, up from $49.6 million in 2024, while net loss narrowed to $49 million from $137.7 million. Operating expenses fell 21% YoY to $104.5 million, and Q4 gross margin improved to 65% after a licensing revenue surge. The company’s...
GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025...
GoHealth reported full‑year 2025 results showing a sharp decline in revenue and profitability as it intentionally scaled back Medicare Advantage activity. Net revenues dropped 55% to $361.8 million, and Adjusted EBITDA swung to a $35.1 million loss. The company emphasized a consumer‑first...
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
Nanobiotix posted full‑year 2025 results showing a revenue rebound to roughly $35.5 million and a net loss of $26 million, a 65% YoY improvement. The company secured a non‑dilutive royalty financing of up to $71 million, extending its cash runway to early 2028 with...
XBP Global Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
XBP Global reported FY 2025 revenue of $791 million, a 9.4% decline, while GAAP net income surged to $1.1 billion after a $215 million loss the prior year. Pro forma Adjusted EBITDA fell 13.1% to $90.7 million, reflecting integration costs from the July 2025 BPA acquisition....
Tempest Reports Year End 2025 Financial Results and Provides Business Update
Tempest Therapeutics reported its 2025 financial results, highlighting a strategic acquisition of dual‑targeting CAR‑T assets from Factor Bioscience and encouraging early data from its lead candidate TPST‑2003 in relapsed/refractory multiple myeloma. The REDEEM‑1 Phase 1/2a trial showed a 100% complete response...
Rezolve Ai Delivers 543% H2 Growth; Raises 2026 Revenue Guidance to $360M as Platform Achieves Global Infrastructure Scale
Rezolve Ai reported a record $46.8 million GAAP revenue for 2025, far exceeding market expectations, and ended the year with a $19.4 million December MRR that translates to a $232 million annualized run rate. The company’s gross margin reached 66 % and core software margins...
Standard Lithium Reports Fourth Quarter and Full Year 2025 Results
Standard Lithium announced a series of Q4 2025 milestones, including a Definitive Feasibility Study for the SWA Project that targets 22,500 tonnes of lithium carbonate per year and the filing of an inferred resource for the Franklin Project, which boasts the highest...
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Unicycive Therapeutics reported FY 2025 results, highlighting the FDA’s acceptance of its oxylanthanum carbonate (OLC) New Drug Application resubmission with a PDUFA target date of June 29 2026. The company is preparing commercial operations for a potential Q3 2026 launch, while its cash balance...
Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results
Mulvihill Canadian Bank Enhanced Yield ETF reported a $34.8 million USD increase in net assets for 2025, bringing total net assets to roughly $96.6 million USD ($11.86 per unit). The fund paid $6.4 million USD in cash distributions, equating to $0.52 per unit....
Manhattan Bridge Capital, Inc. Reports 2025 Results
Manhattan Bridge Capital reported 2025 net income of $5.11 million, or $0.45 per share, an 8.6% decline from the prior year. Total revenue fell 10.6% to $8.67 million, driven by lower interest income and reduced loan origination fees. Operating expenses decreased 13.2%...
Paul Mueller Company Announces Its Fourth Quarter Earnings of 2025
Paul Mueller Company reported a strong fourth‑quarter 2025, posting net sales of $94.1 million—up 34% year‑over‑year—and net income of $13.2 million. Full‑year results showed revenue of $287 million and net income of $34.7 million, driving earnings per share to $14.73 for the quarter and...
Financial Results for the Fourth Quarter of 2025
Helios Fairfax Partners reported record net earnings of $40.5 million for 2025, the highest since its 2020 inception, driven by a 17% increase in portfolio investments to $463.7 million. Book value per share climbed 9.9% to $4.22, and the company realized $25.2 million...
Vantiva - Estimated Operational Results Full Year 2025
Vantiva reported estimated 2025 results showing a 7% drop in sales to €1.736 bn (about $1.9 bn), driven mainly by a weaker dollar and a steep decline in its Video segment. Adjusted EBITDA surged 33% to €145 mn (≈$157 mn), reflecting cost efficiencies and...
IBA Delivers Strong FY 2025 Results with Solid Execution in All Segments
IBA reported FY 2025 revenue of €620 million (≈$682 million), a 24% increase driven by a 44% surge in its Clinical segment. Adjusted EBIT rose 58% to €27.4 million (≈$30 million) and net profit grew 38% to €12.7 million, while gross margin slipped to 32.2% due...
Lassonde Industries Inc. Announces Its Q4 and Fiscal 2025 Results
Lassonde Industries reported fiscal 2025 sales of $2.14 billion USD, a 7% increase year‑over‑year, driven by price adjustments in Canada and higher U.S. volumes. Quarterly results showed Q4 revenue of $560 million USD, up 4%, with operating profit of $52 million USD and...
LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update
LeonaBio announced it has secured an exclusive global license for the Phase 3 lasofoxifene program, a novel selective estrogen receptor modulator aimed at ESR1‑mutated metastatic breast cancer, and raised $90 million in a private placement that could expand to $236 million with warrant...
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
Sanuwave Health reported record Q4 and full‑year 2025 results, with quarterly revenue of $13.4 million—a 29.7 percent increase—and annual revenue of $44.1 million, up 35 percent from 2024. Gross margin slipped to 74.7 percent in Q4 due to a $486 k inventory write‑off, while adjusted EBITDA...
Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates
Inspira Technologies reported full‑year 2025 results, highlighting the transition of its ART100 respiratory support system from clinical validation to early commercial deployment. The company secured $49.5 million in binding purchase orders, with initial revenues of $289 thousand and a net loss of...
Partners Value Split Corp. Announces 2025 Annual Results
Partners Value Split Corp. reported $94 million of income available for distribution for 2025, up from $85 million the prior year, driven by higher Brookfield dividend rates. Net comprehensive income dropped to $1.35 billion, reflecting weaker unrealized gains on its Brookfield holdings. The...
Partners Value Investments Inc. Announces 2025 Annual Results
Partners Value Investments Inc. reported its 2025 financial results, showing a net loss of US$1.4 billion, a significant improvement from the US$3.8 billion loss recorded in 2024. The reduction stemmed mainly from lower remeasurement losses on retractable common shares, which fell to...
Partners Value Investments L.P. Announces 2025 Annual Results
Partners Value Investments L.P. posted 2025 net income of $69 million, down from $74 million a year earlier, as foreign‑currency translation losses outweighed higher investment income and valuation gains. The partnership’s fully diluted net asset value (NAV) climbed to $9.59 billion, up 21%...
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
Ascentage Pharma reported unaudited 2025 results, showing product sales surged 90% to $82.1 million while total revenue fell 41.5% after a $92.9 million drop in intellectual‑property income. Olverembatinib generated $62.2 million, up 81% YoY, and the newly launched Lisaftoclax contributed $10.1 million in its...
Press Release - Fiscal-Year 2025 Results: AFL Group Delivers Record Results, Doubling Its Net Profit
AFL Group posted record fiscal‑year 2025 results, doubling net profit to €10.8 million (about $11.9 million) and lifting net banking income 28% to €30.8 million ($33.9 million). The bank’s gross operating income surged 70% to €13.3 million, while its CET1 capital ratio climbed to 59.45%...
JBS Reports Record Revenue of US$ 86.2 Billion and Closes 2025 with US$ 2 Billion in Net Income
JBS announced record full‑year 2025 revenue of $86.2 billion, a 12% increase over 2024, and net income of $2 billion, up 13%. Earnings per share rose 15% to $1.89, while adjusted EBITDA reached $6.8 billion with a 7.9% margin. Strong contributions came from...
17 Education & Technology Group Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
17 Education & Technology Group Inc. reported Q4 2025 revenue of RMB 38.9 million ($5.6 million), a 6% year‑over‑year increase, while full‑year revenue dropped 44% to RMB 106.0 million ($15.2 million). Gross margins rose to 46.1% in Q4 and 47.8% for the year, reflecting a shift...
Erdene Announces 2025 Results - Provides Bayan Khundii Gold Mine and Exploration Update
Erdene Resource Development completed construction of the high‑grade Bayan Khundii Gold Mine in Q3 2025 and began production in September, selling 7,434 oz of gold at a weighted‑average $4,187 per ounce, generating roughly $31 million in gross revenue. The mill operates near its 85,000‑oz...
Skeena Reports Fourth Quarter and Annual 2025 Financial Results
Skeena Resources Limited released its fourth‑quarter and full‑year 2025 financial results, reaffirming that the Eskay Creek gold‑silver project in British Columbia is fully permitted and now under construction. The company targets initial production and positive cash flow in the second...
Epsilon Announces Full Year 2025 Results
Epsilon Energy reported full‑year 2025 results, posting $51.6 billion in total revenue, a 64% year‑over‑year increase. Adjusted EBITDA surged 75% to $30.7 billion and adjusted net income rose to $21.3 billion, while cash and short‑term investments grew 36% to $9.5 billion. Production jumped sharply,...
Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results
Glass House Brands reported fourth‑quarter 2025 revenue of $38.9 million, in line with guidance but down from $53 million a year earlier, while full‑year 2025 revenue fell 9% to $182 million. Adjusted EBITDA turned positive at $17 million for the year, yet operating cash...
Comstock Announces Full Year 2025 Achievements and Results
Comstock Inc. reported full‑year 2025 results and outlined an aggressive 2026 outlook, highlighted by a $57.5 million equity raise that eliminated all debt and boosted cash to $56.1 million. The company secured permits for its first industry‑scale solar‑panel recycling plant in Nevada...
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Absci Corporation announced that its AI‑designed antibody ABS‑201 has been dosed in the first three single‑ascending‑dose cohorts of the Phase 1/2a HEADLINE trial, showing favorable safety and early hair‑growth signals in human ex vivo studies. The company also unveiled Origin‑1, a generative‑AI...
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights
Biomea Fusion announced its FY 2025 results, reporting $56.2 million in cash and a net loss of $61.8 million, roughly half the loss recorded a year earlier. The company highlighted durable 52‑week HbA1c reductions of 1.2 % from icovamenib in type 2 diabetes and launched...
HomesToLife Delivers 97% Jump in FY2025 Net Profit to US$16.6 Million
HomesToLife Ltd reported FY2025 net profit of $16.6 million, a 97% jump from the prior year, driven by a 13% rise in net revenue to $377.9 million. Export sales grew 12% to $349.6 million, with Europe and North America leading the expansion, while...
Kandal M Venture Limited Announces Financial Results for the Six Months Ended September 30, 2025
Kandal M Venture Limited reported a 17% revenue decline to $7.9 million for the six months ended September 30 2025, driven primarily by higher U.S. import tariffs and related discounts. Gross profit fell 34.7% and margin slipped to 18.7% as material and labor...
Conifex Announces 2025 Year-End and Fourth Quarter Results
Conifex Timber Inc. posted a 2025 full‑year loss of $35.7 million, with EBITDA of negative $27.5 million, widening the deficit from the prior year. Revenue rose 7% to $101 million, but higher softwood lumber duties and a 10% Section 232 tariff pushed duty costs...
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Xilio Therapeutics reported a strong cash position of $137.5 million, extending its runway to the end of 2027, and highlighted significant pipeline advances. The company plans to file an IND for its bispecific PD‑1/masked IL‑2 candidate XTX501 in mid‑2026 and start...
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Cabaletta Bio announced its Q4 and full‑year 2025 results, highlighting a surge in R&D spending to $142.7 million and a cash balance of $133.6 million. The company is advancing its CAR‑T cell therapy rese‑cel, with a registrational BLA for myositis slated for...
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Arbutus Biopharma announced a $950 million upfront settlement from Moderna, with a potential $1.3 billion contingent payment, strengthening its cash position to $91.5 million. The company reported $14.1 million revenue for 2025, driven by license milestones, while cutting R&D expenses by $28.8 million. Clinical progress...
WeRide Reports Record Full Year 2025 Revenue of RMB684.6 Million, Up 90% Year over Year
WeRide announced full‑year 2025 revenue of $97.9 million, a 90% increase year‑over‑year, driven by a 310% surge in product sales and a 210% jump in robotaxi revenue. The company’s robotaxi fleet expanded to 1,125 vehicles operating in 12 countries, while gross...